Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2789 of 5804
-
Vitamin B12 boosts diabetes Drug's power in new study
Disease control CompletedThe current study was conducted to evaluate the prognostic implications of vitamin B12 admission on BMI and HbA1c levels in type 2 diabetic patients treated with Dapagliflozin as a routine medication.
Phase: NA • Sponsor: Al-Balqa Applied University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Patient's own immune cells plus drug tested against tough melanoma
Disease control OngoingThis phase I/II trial tests the safety and side effects of LN-144 (Lifileucel) and pembrolizumab in treating patients with stage IIIB-D or stage IV melanoma that has spread to nearby tissue or lymph nodes. Biological therapies, such as LN-144 (Lifileucel), use substances made fro…
Phase: PHASE1 • Sponsor: Richard Wu • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Veterans' heart failure study tests simple knee exercise fix
Knowledge-focused Recruiting nowHeart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care System. Exercise intolerance is a common complication experienced by patients with HFpEF, perpetuating physical inactivity a…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New hope for IgG4 patients: which drug combo works best?
Disease control Recruiting nowThis study has been designed as a 12-month, open-label randomized controlled clinical trial. The study aims to compare the efficacy and safety of two treatment strategies in IgG4-RD patients with superficial organ involvement: prednisone plus iguratimod and prednisone plus leflun…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Step by step: walking program shows promise for lupus fatigue
Symptom relief CompletedBackground: Fatigue is a major concern to individuals with lupus, persisting even when disease activity is clinically minimal, and impacting almost all quality of life domains. Studies show cross-sectional correlations between fatigue and physical activity levels in lupus. Some p…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can magnetic pulses ease nerve pain in spinal injury?
Symptom relief CompletedNeuropathic pain is a common complication after spinal cord injury (SCI), which significantly affects the patient's quality of life and may be resistant to pharmacological treatment. In our study, we aimed to evaluate the efficacies of intermittent theta burst (iTBS) and high fre…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Flaxseed oil shows promise for blood sugar control
Disease control CompletedThe findings of previous experiments suggested that alpha linolenic acid (ALA) has been linked to anti-hyperglycemic, and reducing the risk of diabetes.This is a randomized double-blind cross-over trial, aims to study the effect of ALA on glycemic status and human metabolism. Fir…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Fasting diet shows promise for depression in bowel disease
Symptom relief CompletedInflammatory bowel disease (IBD) is a chronic illness characterized by inflammation of the intestine. Many individuals with IBD suffer from depressive symptoms and anxiety which can lead to a decreased quality of life, poor treatment compliance, and higher morbidity and mortality…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 26, 2026 16:34 UTC
-
Can amino acids help anorexia patients regain muscle?
Disease control Recruiting nowAmino acids (AAs) are crucial for protein synthesis, in influencing nutritional status, as sources of vital elements (e.g., nucleotides, neurotransmitters) and as signal molecules for the modulation of gene expression and epigenetic mechanisms. Data on the role of amino acids in …
Phase: NA • Sponsor: Villa Garda Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:45 UTC
-
Family-Powered rehab app may boost ICU sleep and cut stigma
Symptom relief CompletedThis prospective, randomized controlled trial aims to evaluate the efficacy of an Internet-Based, Family-Participatory Early Rehabilitation (IFPER) model compared to standard care for critically ill patients in the Intensive Care Unit (ICU). The study will determine if the IFPER …
Phase: NA • Sponsor: The First Hospital of Hebei Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New hope for glioblastoma? early trial tests tinostamustine
Disease control CompletedThe study is designed as an open label, multi-center, Phase 1 study of single agent tinostamustine, used as adjuvant treatment in patients with newly diagnosed GBM who are MGMT unmethylated and have completed concomitant treatment with temozolomide and radiation. Treatment with a…
Phase: EARLY_PHASE1 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New registry aims to find best blood thinner combo for rare clotting disorder
Disease control Recruiting nowThe goal of this registry is to gather more information on the efficacy and safety of various antithrombotic regimens. The registry collects data on patients with antiphospholipid syndrome and an arterial event within the past 12 months, on treatment with either A) a VKA with the…
Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a quick-start opioid treatment keep probationers out of trouble?
Disease control TerminatedThis five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.
Phase: PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a simple supplement shrink fibroids and prevent surgery?
Disease control Recruiting nowThe study will evaluate the impact on uterine fibroids' volume of a combination of natural molecules including Epigallocatechin gallate, Vitamin D, D-chiro-inositol and Vitamin B6. The patients will be evaluated at baseline and after three months of treatment with placebo or pro…
Phase: NA • Sponsor: Lo.Li.Pharma s.r.l • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Online sleep program could help TBI patients get better rest
Symptom relief Recruiting nowSleep disturbance is a common condition following traumatic brain injury (TBI) and impairs recovery and quality of life. While efficacious interventions exist many are not accessible to all patients due to a variety of factors (e.g., rurality, access to providers). Further, many …
Phase: NA • Sponsor: VA Eastern Colorado Health Care System • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
How often should you get up from your chair? new study aims to find out
Knowledge-focused Recruiting nowThe purpose of this Phase 1 research study is to answer two questions: (1) How frequent should periods of prolonged sedentary time be interrupted? and (2) What is the appropriate duration or length of time of these breaks in sedentary time? To address these questions, this projec…
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Acupuncture needles vs. sham: does it really help Alzheimer's?
Symptom relief CompletedTo determine if adjunctive acupuncture acts as an AD treatment rather than a placebo.
Phase: NA • Sponsor: Shanghai Institute of Acupuncture, Moxibustion and Meridian • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can a drug plus nerve training restore leg movement after paralysis?
Disease control CompletedThe purpose of this study is to test a strategy to potentiate functional recovery of lower limb motor function in individuals with spinal cord injury (SCI). The FDA approved drug, Dalfampridine (4-AP). 4-AP will be used in combination of Spike-timing-dependent plasticity (STDP) s…
Phase: EARLY_PHASE1 • Sponsor: Shirley Ryan AbilityLab • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Simple breathing exercises could ease asthma symptoms
Symptom relief OngoingThis study aims to implement the evidence-based intervention breathing retraining into clinical care of patients with symptomatic asthma irrespective of asthma severity or comorbidities, and in a diverse multicentre setting to evaluate implementation outcomes. This will meet pati…
Phase: NA • Sponsor: Naestved Hospital • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New mesh aims to cut hernia recurrence in 5-Year trial
Disease control OngoingThe purpose of this study is to evaluate the safety and performance of the 4DMESH® used in (robot-assisted) laparoscopic inguinal and femoral hernia repair. The goal of the study will be achieved by assessing the prevalence of recurrences, pain, quality-of-life (QoL), return to d…
Phase: NA • Sponsor: Cousin Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC